Diagnostic value of plasma miR-21 in pancreatic cancer

World Chinese Journal of Digestology

Volumn 19, Issue 8, 2011, Pages 860-863

  Liu, Jian Qiang ^a   Gao, Jun ^a   Ren, Yan ^a   Wang, Xiao Wei ^a   Wang, Wei Wei ^a   Lu, Hua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis; Pancreatic cancer; Plasma microRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 21;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC PANCREATITIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PANCREAS CANCER; PANCREAS DUCT; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

EID: 79957791053     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kuhlmann KF, de Castro SM, Wesseling JG, ten Kate FJ, Offerhaus GJ, Busch OR, van Gulik TM, Obertop H, Gouma DJ. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 2004; 40: 549-558
2. Slesak B, Harlozinska-Szmyrka A, Knast W, Sedlac-zek P, van Dalen A, Einarsson R. Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9. Cancer 2000; 89: 83-88
3. Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur J Surg Oncol 2005; 31: 164-169
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297
5. Slack FJ, Weidhaas JB. MicroRNA in cancer prognosis. N Engl J Med 2008; 359: 2720-2722
6. Visone R, Croce CM. MiRNAs and cancer. Am J Pathol 2009; 174: 1131-1138
7. Mirnezami AH, Pickard K, Zhang L, Primrose JN, Packham G. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 2009; 35: 339-347
8. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Ras-senti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99: 15524-15529
9. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-1908
10. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD. Expression profling identifes mi-croRNA signature in pancreatic cancer. Int J Cancer 2007; 120: 1046-1054
11. Feber A, Xi L, Luketich JD, Pennathur A, Landre-neau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008; 135: 255-260; discussion 260
12. Yanaihara N, Caplen N, Bowman E, Seike M, Ku-mamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. Unique microRNA molecular profles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198
13. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC. MicroRNA expression profles associated with prognosis and therapeutic outcome in colon adeno-carcinoma. JAMA 2008; 299: 425-436
14. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-6033
15. Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 2008; 12: 2171-2176
16. Schmiegel WH, Kreiker C, Eberl W, Arndt R, Classen M, Greten H, Jessen K, Kalthoff H, Soehendra N, Thiele HG. Monoclonal antibody defnes CA 19-9 in pancreatic juices and sera. Gut 1985; 26: 456-460